Nebu~Flow raises £1.7m to advance its medical nebuliser technology
Foresight Williams Technology led the oversubscribed round alongside several regional and specialist investors.
A medical device developer creating surface acoustic wave nebulisers designed to handle next-generation respiratory pharmaceuticals.
Medical device company Nebu~Flow has secured £1.7m in an oversubscribed funding round led by Foresight Williams Technology. The transaction also saw participation from Science Creates Ventures, Ascension Life Fund, and SIS Ventures. The capital will be directed towards accelerating product development and advancing the company commercialisation strategy.
Spun out from the University of Glasgow, Nebu~Flow builds surface acoustic wave nebuliser architecture designed to improve drug administration efficiency and accommodate biologics that are typically incompatible with standard devices. The company operates within a global nebuliser market valued at over $1bn.
From the founder
"We are incredibly pleased to be partnering with Foresight as Nebu~Flow continues to invest in product development and our commercial strategy. In a very exciting period for the industry, Foresight’s support will be vital in our next chapter of growth."
Elijah Nazarzadeh
CEO at Nebu~Flow
Investor perspective
"We are excited to announce our support for such a forward thinking and innovative business. Nebu~Flow’s development of delivery mechanisms tailored to specific drugs represents an opportunity to expand the market and improve patient outcomes. Foresight Williams Technology’s expertise will offer significant value as the Company develops its products, and we look forward to working with the team at Nebu~Flow during the next stage of their growth."
Bill Yost
Investment Manager, Foresight
Use of funds
- 01Continue product development
- 02Accelerate go-to-market
